Last reviewed · How we verify
NCT06328088
Vegetarian Versus Non Vegetarian Based Diet in the Recurrence of Hepatic Encephalopathy in Patients With Cirrhosis: An Open Label Pilot Study
trial testing Non vegetarian in Hepatic Encephalopathy in 40 participants. Status unknown.
16 April 2024
Quick facts
| Lead sponsor | Sir Ganga Ram Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 16 February 2024 |
| Primary completion | 16 April 2024 |
| Estimated completion | 16 October 2024 |
| Sites | 1 location across India |
Drugs / interventions tested
- Non vegetarian
Conditions studied
- Hepatic Encephalopathy — all drugs for Hepatic Encephalopathy →
Sponsor
Sir Ganga Ram Hospital
Who can join
Adults 18 to 80, any sex, with Hepatic Encephalopathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Earlier protein restriction was advocated in the treatment of HE but later this concept was refuted and increase protein intake was advocated in patients with HE. Diet in patients during an episode HE is also not known. It is advisable based on many case reports or case series that vegetable-based diet during the episode of HE is better than animal-based diet as it reduces ammonia level and other false neurotransmitters in brain and helps in early recovery of, HE . However, diet in patients who had recovered from an episode of, HE is not known and what type of protein (vegetarian or non-vegetarian) should be taken to prevent another episode of HE has never been evaluated. In India majority of the patients are vegetarian and patients with cirrhosis are malnourished and lack protein in their diet as per our previous published study
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The future of clinical trials of gut microbiome therapeutics in cirrhosis.
Bloom PP, Chung RT. · · 2025 · cited 4× · PMID 39717506 · DOI 10.1016/j.jhepr.2024.101234
Verify or expand the search:
- PubMed search for NCT06328088
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hepatic Encephalopathy
Currently open trials in the same condition.
- NCT07521332 — Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis · Phase 4 · recruiting
- NCT07418008 — The Liver Cirrhosis Cognitive Decline Scale (LiCCoS) · recruiting
- NCT06953921 — Correlation Between Serum Albumin Level and Severity of Hepatic Encephalopathy in Patients With Chronic Liver Disease in · recruiting
- NCT07437638 — Clinical Efficacy and Survival Prediction Analysis of Transjugular Intrahepatic Portosystemic Shunt in Patients With Liv · active not recruiting
- NCT06425380 — Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy · NA · recruiting
Other Sir Ganga Ram Hospital trials
Trials by the same sponsor.
- NCT06986109 — Effect of Subanaesthetic Dose of Ketamine on Depth of Anaesthesia Consistency · NA · recruiting
- NCT06218836 — Effect of Inflated Versus Non-inflated Endotracheal Tube on Sore Throat · NA · recruiting
- NCT05725135 — Effect of Gender on Propofol Requirement · completed
- NCT05430750 — Global Warming Impact of Nitrous Oxide · Phase 4 · completed
- NCT05305313 — Evaluation of Propofol Dosing Based on Total Body Weight Using Closes-loop Anaesthesia Delivery System · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06328088 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sir Ganga Ram Hospital
- Last refreshed: 25 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06328088.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing